DV
Dividend Vision

ENTA — Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Inc (ENTA)

Total return is -23.4% over the past 13.4 years, 553.9 points behind SPY at 530.5%. Its deepest 1-year drawdown was 34.3%.

ENTA is an equity stock that trades as an individual security rather than a diversified fund. As a single-company holding, it carries company-specific risk and does not provide the diversification typical of ETFs. The stock does not currently distribute dividends, making it unsuitable for income-focused investors seeking regular payouts.

ENTA key facts

Asset type
Stock
Asset class
Equity
Inception date
03/21/2013
Last close
$13.16
Market cap
$399,536,928
Average volume
173405.0
Beta
0.967
Payout ratio
0.0
Forward P/E
44.0529
EPS
$-2.60